ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,300.01
0.30%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,325.17
-0.03%
Brent Oil
81.135
0.41%
Bitcoin
68,858.91
1.64%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Enzo Biochem Inc (ENZ)

  7. Enzo Biochem Inc (ENZ) News

Enzo Biochem (ENZ)

Enzo Biochem Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ENZ
DateTimeSourceHeadlineSymbolCompany
24/05/202421:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
24/05/202421:44Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
13/03/202420:26GlobeNewswire Inc.Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateNYSE:ENZEnzo Biochem Inc
28/02/202400:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
27/02/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
27/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
14/02/202415:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENZEnzo Biochem Inc
13/02/202414:35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENZEnzo Biochem Inc
03/02/202402:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
03/02/202402:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
03/02/202402:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
01/02/202413:33Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
21/12/202321:48Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNYSE:ENZEnzo Biochem Inc
21/12/202321:15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNYSE:ENZEnzo Biochem Inc
15/12/202321:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ENZEnzo Biochem Inc
15/12/202321:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
28/11/202322:16Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NYSE:ENZEnzo Biochem Inc
03/11/202321:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ENZEnzo Biochem Inc
30/10/202321:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
30/10/202320:50Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
11/09/202322:14Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:ENZEnzo Biochem Inc
06/09/202302:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
28/07/202322:19Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:ENZEnzo Biochem Inc
24/07/202321:32Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
24/07/202321:20Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:ENZEnzo Biochem Inc
19/07/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:ENZEnzo Biochem Inc
19/07/202302:42Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:ENZEnzo Biochem Inc
18/07/202318:19Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NYSE:ENZEnzo Biochem Inc
17/07/202318:38Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
10/07/202322:30Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NYSE:ENZEnzo Biochem Inc
 Showing the most relevant articles for your search:NYSE:ENZ

Your Recent History

LSE
BP.
Bp
LSE
RKH
Rockhopper Exploration
LSE
JLP
Jubilee Metals
LSE
CHLL
Chill Brands
LSE
BIRD
Blackbird
LSE
GSK
Gsk
LSE
GKP
Gulf Keystone Petroleum
LSE
IES
Invinity Energy Systems
LSE
AAZ
Anglo Asian Mining
LSE
DEC
Diversified Energy
LSE
TERN
Tern
LSE
POS
Plexus
LSE
PHE
Powerhouse Energy
LSE
DELT
Deltic Energy
LSE
BOO
Boohoo
LSE
UJO
Union Jack Oil
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved